On the other hand, PPARγ agonists administration to HCC cell lines promoted cell cycle arrest, apoptosis, and anoikis [94, 95], sensitized the cells to 5-fluorouracil antitumoural activity [96], and inhibited migration of these cells [97]. The gene discussed is PPARG; the disease is hepatocellular carcinoma.